Radiolabeled anti–prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer (CRPC).
Monte Carlo 3D dose-check calculations help clinical physicists maintain confidence in their patient-specific QA for hard-to-treat disease indications Independent viewpoint: given the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results